Author: Peter Mansell

Industry, stakeholders push on EU trial times

TheCouncil of the European Union must preserve the competitive timelinesfor assessment set out in the European Commission’s proposedregulation on clinical trials if it wants to keep Europe at thecutting edge of biopharmaceutical innovation, a coalition ofpharmaceutical and biotechnology industry associations, researchersand patient groups insists.

Read More

Patient involvement boosts confidence in research studies

Knowing that a health-research study had been reviewed by a Research Ethics Committee (REC) involving members of the public, or that patients had a role in ensuring the study information was easily digestible, would boost public confidence in the research endeavour, a UK survey has found.

Read More